Sequentia Biotech is a bioinformatics company that offers services and tools that transform genomic data into knowledge.
Sequentia Biotech has raised $11.2M in total funding. The most recent round was Series A. The last funding was announced in September 2024.
Sequentia Biotech's investors include Seventure Partners, European Innovation Council, EASME.
Sequentia Biotech is headquartered in Barcelona, Spain.
Sequentia Biotech is a bioinformatics company that offers services and tools that transform genomic data into knowledge.
Sequentia Biotech is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sequentia Biotech — Funding & Investors." VCBacked, September 27, 2024, https://www.vcbacked.co/company/sequentia-biotech. Accessed July 19, 2026.
VCBacked. (2024). Sequentia Biotech — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/sequentia-biotech
{{cite web |title=Sequentia Biotech — Funding & Investors |url=https://www.vcbacked.co/company/sequentia-biotech |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated